Literature DB >> 32097460

A practical approach to evaluating postoperative thrombocytopenia.

Leslie Skeith1,2, Lisa Baumann Kreuziger3,4, Mark A Crowther5, Theodore E Warkentin5,6.   

Abstract

Identifying the cause(s) of postoperative thrombocytopenia is challenging. The postoperative period includes numerous interventions, including fluid administration and transfusion of blood products, medication use (including heparin), and increased risk of organ dysfunction and infection. Understanding normal thrombopoietin physiology and the associated expected postoperative platelet count changes is the crucial first step in evaluation. Timing of thrombocytopenia is the most important feature when differentiating causes of postoperative thrombocytopenia. Thrombocytopenia within 4 days of surgery is commonly caused by hemodilution and increased perioperative platelet consumption prior to thrombopoietin-induced platelet count recovery and transient platelet count overshoot. A much broader list of possible conditions that can cause late-onset thrombocytopenia (postoperative day 5 [POD5] or later) is generally divided into consumptive and destructive causes. The former includes common (eg, infection-associated disseminated intravascular coagulation) and rare (eg, postoperative thrombotic thrombocytopenic purpura) conditions, whereas the latter includes such entities as drug-induced immune thrombocytopenia or posttransfusion purpura. Heparin-induced thrombocytopenia is a unique entity associated with thrombosis that is typically related to intraoperative/perioperative heparin exposure, although it can develop following knee replacement surgery even in the absence of heparin exposure. Very late onset (POD10 or later) of thrombocytopenia can indicate bacterial or fungal infection. Lastly, thrombocytopenia after mechanical device implantation requires unique considerations. Understanding the timing and severity of postoperative thrombocytopenia provides a practical approach to a common and challenging consultation.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32097460      PMCID: PMC7042990          DOI: 10.1182/bloodadvances.2019001414

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  36 in total

Review 1.  How I diagnose and manage HIT.

Authors:  Theodore E Warkentin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Heparin-induced thrombocytopenia: pathogenesis and management.

Authors:  Theodore E Warkentin
Journal:  Br J Haematol       Date:  2003-05       Impact factor: 6.998

3.  Blunted rise in platelet count in critically ill patients is associated with worse outcome.

Authors:  M W Nijsten; H J ten Duis; J G Zijlstra; R J Porte; J H Zwaveling; J C Paling; T H The
Journal:  Crit Care Med       Date:  2000-12       Impact factor: 7.598

4.  Frequency and Clinical Impact of Platelet Factor 4-Specific Antibodies in Patients Undergoing Extracorporeal Membrane Oxygenation.

Authors:  Caroline Vayne; Marc-Antoine May; Thierry Bourguignon; Eric Lemoine; Eve-Anne Guery; Jérôme Rollin; Yves Gruel; Claire Pouplard
Journal:  Thromb Haemost       Date:  2019-05-26       Impact factor: 5.249

5.  Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.

Authors:  C Pouplard; M A May; S Iochmann; J Amiral; A M Vissac; M Marchand; Y Gruel
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

6.  Differences between the effects of EDTA and citrate anticoagulants on platelet count and mean platelet volume.

Authors:  R L McShine; S Sibinga; B Brozovic
Journal:  Clin Lab Haematol       Date:  1990

7.  A 14-year study of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

8.  Association of thrombocytopenia with the use of intra-aortic balloon pumps.

Authors:  R H Vonderheide; R Thadhani; D J Kuter
Journal:  Am J Med       Date:  1998-07       Impact factor: 4.965

9.  An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.

Authors:  Theodore E Warkentin; Robin S Roberts; Jack Hirsh; John G Kelton
Journal:  Arch Intern Med       Date:  2003-11-10

10.  Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.

Authors:  S Selleng; B Malowsky; U Strobel; A Wessel; T Ittermann; H-G Wollert; T E Warkentin; A Greinacher
Journal:  J Thromb Haemost       Date:  2009-09-28       Impact factor: 5.824

View more
  3 in total

1.  Postsurgical Thrombotic Microangiopathy and Deregulated Complement.

Authors:  Thijs T W van Herpt; Sjoerd A M E G Timmermans; Walther N K A van Mook; Bas C T van Bussel; Iwan C C van der Horst; Jos G Maessen; Ehsan Natour; Pieter van Paassen; Samuel Heuts
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

Review 2.  Heparin Induced Thrombocytopenia for the Perioperative and Critical Care Clinician.

Authors:  Ingrid Moreno-Duarte; Kamrouz Ghadimi
Journal:  Curr Anesthesiol Rep       Date:  2020-08-29

Review 3.  A Comprehensive Review of Thrombocytopenia With a Spotlight on Intensive Care Patients.

Authors:  Ratnam K Santoshi; Reema Patel; Neil S Patel; Varinder Bansro; Gurdeep Chhabra
Journal:  Cureus       Date:  2022-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.